Business Description
Medivolve Inc
NAICS : 541380
SIC : 8681
ISIN : CA58503M4083
Description
Medivolve Inc is a healthcare technology and services company. It is engaged in finding and developing disruptive technologies, groundbreaking innovations, and partnerships to help combat COVID-19 and transform human health management. The company operated one reportable segment, the COVID Testing facilities across the United States Of America.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.6 | |||||
| Equity-to-Asset | -6.66 | |||||
| Debt-to-Equity | -0.11 | |||||
| Debt-to-EBITDA | -0.32 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -70.59 | |||||
| Beneish M-Score | -30.98 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -74.9 | |||||
| 3-Year EBITDA Growth Rate | 71.1 | |||||
| 3-Year FCF Growth Rate | 59.2 | |||||
| 3-Year Book Growth Rate | 16.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.06 | |||||
| 9-Day RSI | 46.7 | |||||
| 14-Day RSI | 47.81 | |||||
| 6-1 Month Momentum % | -90.74 | |||||
| 12-1 Month Momentum % | -96.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.08 | |||||
| Quick Ratio | 0.08 | |||||
| Cash Ratio | 0.06 | |||||
| Days Inventory | 53.83 | |||||
| Days Sales Outstanding | 1542.22 | |||||
| Days Payable | 4371.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -39.3 | |||||
| Shareholder Yield % | 54.13 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.3 | |||||
| Operating Margin % | -230.49 | |||||
| Net Margin % | -796.56 | |||||
| FCF Margin % | -139.29 | |||||
| ROA % | -139.46 | |||||
| ROIC % | -90.98 | |||||
| ROC (Joel Greenblatt) % | -1243.92 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.39 | |||||
| EV-to-EBIT | -0.14 | |||||
| EV-to-EBITDA | -0.15 | |||||
| EV-to-Revenue | 0.38 | |||||
| EV-to-FCF | -0.27 | |||||
| Earnings Yield (Greenblatt) % | -714.29 | |||||
| FCF Yield % | -356.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medivolve Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.415 | ||
| EPS (TTM) (€) | -0.207 | ||
| Beta | 0 | ||
| Volatility % | 3924.87 | ||
| 14-Day RSI | 47.81 | ||
| 14-Day ATR (€) | 0.003845 | ||
| 20-Day SMA (€) | 0.005575 | ||
| 12-1 Month Momentum % | -96.35 | ||
| 52-Week Range (€) | 0.0005 - 0.0785 | ||
| Shares Outstanding (Mil) | 27.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medivolve Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medivolve Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medivolve Inc Frequently Asked Questions
What is Medivolve Inc(FRA:4NCA)'s stock price today?
The current price of FRA:4NCA is €0.00. The 52 week high of FRA:4NCA is €0.08 and 52 week low is €0.00.
When is next earnings date of Medivolve Inc(FRA:4NCA)?
The next earnings date of Medivolve Inc(FRA:4NCA) is .
Does Medivolve Inc(FRA:4NCA) pay dividends? If so, how much?
Medivolve Inc(FRA:4NCA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers